Convalescent Plasma: Therapeutic Hope or Hopeless Strategy in the SARS-CoV-2 Pandemic.

Authors:
Sullivan HC; Roback JD.

Journal:
Transfus Med Rev

Publication Year: 2020

DOI:
10.1016/j.tmrv.2020.04.001

PMCID:
PMC7179481

PMID:
32359788

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Transfus Med Rev

Abbreviation: Transfus Med Rev

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Production and Quality Assurance of Human Polyclonal Hyperimmune Immunoglobulins Against SARS-CoV-2.
Burnouf T; Gathof B; Bloch EM and 11 more (2022) - Transparency Score: 3/6
A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a Framework for…
Liao G; Zheng K; Lalu MM and 2 more (2020) - Transparency Score: 2/6
A Scoping Review of Registered Clinical Trials of Convalescent Plasma for COVID-19 and a Framework …
Zheng K; Liao G; Lalu MM and 3 more (2020) - Transparency Score: 1/6
International Survey of Trials of Convalescent Plasma to Treat COVID-19 Infection.
Murphy M; Estcourt L; Grant-Casey J and 1 more (2020) - Transparency Score: 1/6
New Emerging Developments of Platelets in Transfusion Medicine.
Stolla M; Kapur R; Semple JW. (2020) - Transparency Score: 0/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors have no conflict of interest to disclose in relation to the submitted review."

Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025